Chemical synthesis and biological evaluation of an antimicrobial peptide gonococcal growth inhibitor

Amino Acids

Volumn 43, Issue 6, 2012, Pages 2279-2283

  Wade, John D ^a   Lin, Feng ^a   Hossain, Mohammed Akhter ^a   Dawson, Raymond M ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b DEFENCE SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

Author keywords

Antimicrobial peptide; Difficult sequence; Gonococcal growth inhibitor 1; Haemolytic activity; Solid phase peptide synthesis

Indexed keywords

GONOCOCCAL GROWTH INHIBITOR 1; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ACETYLATION; AMINO TERMINAL SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS ANTHRACIS; BACILLUS SUBTILIS; BURKHOLDERIA THAILANDENSIS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG PURIFICATION; DRUG SELECTIVITY; DRUG SYNTHESIS; ERYTHROCYTE; ESCHERICHIA COLI; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROPHOBICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SOLID PHASE SYNTHESIS;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BACTERIAL PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; HEMOLYSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; STRUCTURE-ACTIVITY RELATIONSHIP;

ESCHERICHIA COLI; LEGIONELLA; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS HAEMOLYTICUS;

EID: 84872678746     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-012-1305-z     Document Type: Article

References (20)

1. Abel Rahman S, El-Kafrawy A, Hattaba A, Anwer MF (2007) Optimization of solid-phase synthesis of difficult peptide sequences via comparison between different improved approaches. Amino Acids 33:531-536 (Pubitemid 47347934)
2. Bathgate RAD, Lin F, Hanson NF, Otvos Jr L, Guidolin A, Giannakis C, Bastiras S, Layfield S, Ferraro T, Ma S, Zhao C, Gundlach AL, Samuel CS, Tregear GW, Wade JD (2006) Relaxin-3: improved synthesis strategy and demonstration of its highaffinity interaction with the relaxin receptor LGR7 both in vitro and in vivo. Biochemistry 45:1043-1053 (Pubitemid 43122269)
3. Beaudet R, Bisaillon JG, Saheb SA, Sylvestre M (1982) Production, purification, and preliminary characterization of a gonococcal growth inhibitor produced by a coagulase-negative staphylococcus isolated from the urogenital flora. Antimicrob Agents Chemother 22:277-283 (Pubitemid 12020120)
4. Dawson RM, Liu CQ (2008) Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Crit Rev Microbiol 34:89-107 (Pubitemid 351878991)
5. Dawson RM, Liu CQ (2010) Disulphide bonds of the peptide protegrin-1 are not essential for antimicrobial activity and haemolytic activity. Int J Antimicrob Agents 36:579-580
6. Dawson RM, Liu CQ (2011) Analogues of peptide SMAP-29 with comparable antimicrobial potency and reduced cytotoxicity. Int J Antimicrob Agents 37:432-437
7. Dawson RM, McAllister J, Liu CQ (2010) Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis. Int J Antimicrob Agents 36:359-363
8. Dawson RM, Fox MA, Atkins HS, Liu CQ (2011) Potent antimicrobial peptides with selectivity for Bacillus anthracis over human erythrocytes. Int J Antimicrob Agents 38:237-242
9. Hossain MA, Bathgate RA, Kong C, Shabanpoor F, Zhang S, Haugaard-Jonsson LM, Rosengren KJ, Tregear GW, Wade JD (2008) Synthesis, conformation and receptor binding activity of human insulin-like peptide 5 (INSL5). ChemBioChem 9:1816-1822
10. Hossain MA, Samuel CS, Binder C, Hewitson TD, Tregear GW, Wade JD, Bathgate RA (2010) The chemically synthesized human relaxin-2 analog, B-R13/17K H2, is an RXFP1 antagonist. Amino Acids 39:409-416
11. Kim J-Y, Park S-C, Hahm K-S, Park Y (2011) C-terminal amidation of PMAP-23: translocation to the inner membrane of Gramnegative bacteria. Amino Acids 40:183-195
12. Lebl M, Krchnak V, Lebl G (1995) Peptide Companion, San Diego, CA. http://www.5z.com/psp/software.shtml
13. Marchand A, Verdon J, Lacombe C, Crapart S, Hechard Y, Berjeaud JM (2011) Anti-Legionella activity of staphylococcal hemolytic peptides. Peptides 32:845-851
14. Milton RC, Milton SCF, Adams PA (1990) Prediction of difficult sequences in solid-phase peptide synthesis. J Am Chem Soc 112:6039-6046 (Pubitemid 20271841)
15. Mutter M, Nefzi A, Sato T, Sun X, Wahl F, Wohr T (1995) Pseudoprolines (psi Pro) for accessing inaccessible peptides. Pept Res 8:145-153
16. Tickler AK, Wade JD (2007) Solid phase synthesis of difficult peptide sequences. In: Coligan JE, Dunn BM, Speicher DW, Wingfield PT (eds) Current protocols in protein science, vol. 50. John Wiley & Sons, New York. Unit 18.8, pp 1-6
17. Tickler AK, Clippingdale AB, Wade JD (2004) Amyloid-b as a difficult sequence in solid phase peptide synthesis. Protein Pept Lett 11:377-384 (Pubitemid 38908585)
18. Watson DC, Yaguchi M, Bisaillon JG, Beaudet R, Morosoli R (1988) The amino acid sequence of a gonococcal growth inhibitor from Staphylococcus haemolyticus. Biochem J 252:87-93
19. White P, Keyte JW, Bailey K, Bloomberg G (2004) Expediting the Fmoc solid phase synthesis of long peptides through the application of dimethyloxazolidine dipeptides. J Pept Sci 10:18-26 (Pubitemid 38100725)
20. Zelezetsky I, Pag U, Antcheva N, Sahl H-G, Tossi A (2005) Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin. Arch Biochem Biophys 434:358-364 (Pubitemid 40082045)